PPARGC1A and Glucose intolerance: A previous study showed that dasatinib could increase the levels of peroxisome proliferative activated receptor gamma coactivator 1 alpha (PGC-1α) in adipose tissue, but exerted an adverse effect on glucose intolerance in obese mice (54).